MITOCHONDRIAL RENEWAL // UROLITHIN A
Urolithin A (marketed as Mitopure) is a gut-derived metabolite of ellagitannins — compounds in pomegranate and walnuts — that most people cannot produce efficiently on their own. Its mechanism is genuinely novel: it triggers mitophagy, the cellular recycling of damaged mitochondria to make room for healthy ones. In a randomized, placebo-controlled trial of 88 middle-aged adults over 4 months (Cell Reports Medicine, 2022), Urolithin A produced roughly a 12% improvement in muscle strength plus clinically meaningful gains in aerobic endurance and the 6-minute walk test. It is one of the few 'longevity supplements' with a real human mechanism and a real human RCT behind it.
- ›Mitopure (Urolithin A) is the studied form and dose — generic 'pomegranate extract' does not reliably deliver Urolithin A.
- ›Best-fit operator: aging muscle, endurance, and cellular-energy maintenance — not an acute performance stimulant.
- ›Compounds over months, like the NAD⁺ vector. Assess against a baseline; this is infrastructure, not a pre-workout.
The realistic yield: a modest, real improvement in muscle function and mitochondrial biomarkers, backed by an actual human RCT — which puts it ahead of most of the longevity-supplement shelf. It moves the mitochondrial floor, not the performance ceiling.
Certainty ends at muscle function and mitochondrial biomarkers in middle-aged and older adults. Direct lifespan extension is UNPROVEN; the largest documented effects are on strength and endurance, not longevity endpoints. Effect sizes are modest. Not a substitute for training.